• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinically important beta-lactamases of gram-negative bacteria: AmpC].

作者信息

Hrabák J

机构信息

Ustav mikrobiologie LF UK a FN v Plzni.

出版信息

Epidemiol Mikrobiol Imunol. 2007 Nov;56(4):155-65.

PMID:18064797
Abstract

Beta-lactamases are the most common cause of beta-lactam resistance in Gram-negative bacteria. With third-generation and fourth-generation cephalosporins being introduced into practice, new beta-lactamases have evolved, able to hydrolyze these antibiotics. AmpC-type beta lactamases (cephalosporinases) are serine enzymes with the ability to hydrolyze penicillins, monobactams and cephalosporins of all generations, including cephamycins. Over the last two decades, transferable plasmid-mediated class C beta-lactamases have been reported with increasing frequency. The genes for resistance to other groups of antibiotics are usually carried on the same mobile element as the AmpC genes. A reliable method for AmpC detection in routine diagnosis has not been available yet. The issue of AmpC-type beta lactamases is summarized, including their identification, interpretation of susceptibility test results and recommended treatment of infection caused by AmpC producers.

摘要

相似文献

1
[Clinically important beta-lactamases of gram-negative bacteria: AmpC].
Epidemiol Mikrobiol Imunol. 2007 Nov;56(4):155-65.
2
[Study of susceptibility and genotype characterization of plasmid-mediated class I cephalosporinase in gram-negative bacteria].革兰阴性菌中质粒介导的Ⅰ类头孢菌素酶的敏感性及基因型特征研究
Zhonghua Jie He He Hu Xi Za Zhi. 2003 Nov;26(11):697-700.
3
[Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].[革兰氏阴性菌临床上重要的β-内酰胺酶:超广谱β-内酰胺酶(ESBL)]
Epidemiol Mikrobiol Imunol. 2007 Aug;56(3):103-11.
4
[Detection of AmpC beta-lactamases in Gram-negative bacteria isolated from urine].[从尿液中分离出的革兰氏阴性菌中产AmpCβ-内酰胺酶的检测]
Epidemiol Mikrobiol Imunol. 2008 Nov;57(4):141-6.
5
[Broad-spectrum beta-lactamases in Gram-negative bacteria].革兰氏阴性菌中的广谱β-内酰胺酶
Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2741-5.
6
Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.在一家法国医院分离出的产AmpC型大肠杆菌临床菌株的分子特征分析
J Antimicrob Chemother. 2008 Mar;61(3):498-503. doi: 10.1093/jac/dkm538. Epub 2008 Feb 4.
7
[Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].[肺炎克雷伯菌属和大肠埃希菌中对头孢西丁耐药或中介的菌株的质粒介导AmpCβ-内酰胺酶类型调查]
Mikrobiyol Bul. 2008 Oct;42(4):545-51.
8
[Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].[实验室中的β-内酰胺酶及其在耐药性中的作用 第一部分:β-内酰胺酶介导的细菌耐药性的演变]
Lijec Vjesn. 2004 Nov-Dec;126(11-12):314-24.
9
New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.新型β-内酰胺酶:临床环境中细菌进化快速响应的范例。
Future Microbiol. 2006 Oct;1(3):295-308. doi: 10.2217/17460913.1.3.295.
10
[Occurrence and mechanisms of resistance to beta-lactam antibiotics in clinically important species of Enterobacter].[临床重要肠杆菌属物种对β-内酰胺类抗生素的耐药性发生情况及机制]
Epidemiol Mikrobiol Imunol. 2001 Aug;50(3):121-30.

引用本文的文献

1
Molecular docking analysis of beta-lactamase from Salmonella species with eicosane.鼠伤寒沙门氏菌β-内酰胺酶与二十烷的分子对接分析
Bioinformation. 2022 Aug 31;18(8):669-674. doi: 10.6026/97320630018669. eCollection 2022.